Goldman Sachs Reiterates Neutral Rating on Tarsus Pharmaceuticals (TARS)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. ROST
5. BILL
6. WMT
7. ADI
8. MRK
9. MRNA
10. MRVL

Go back to Goldman Sachs Reiterates Neutral Rating on Tarsus Pharmaceuticals (TARS)
(NASDAQ: TARS) Delayed: 71.49 -1.95 (2.66%)
Previous Close $73.44    52 Week High $ 
Open $72.81    52 Week Low $ 
Day High $73.42    P/E N/A 
Day Low $70.10    EPS $ 
Volume 538,092